<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02255201</url>
  </required_header>
  <id_info>
    <org_study_id>GPN-2014</org_study_id>
    <nct_id>NCT02255201</nct_id>
  </id_info>
  <brief_title>Pre-Workout on Exercise Performance and Cognition</brief_title>
  <official_title>A Randomized, Double-Blind, Crossover Clinical Trial Comparing the Effects of Four Pre-Workout Beverages on Muscular Strength and Endurance and Cognitive Performance in Healthy Adult Males</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Miami Research Associates</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Glanbia Performance Nutrition</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Miami Research Associates</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the effects of four different pre-workout beverages
      as compared to placebo on muscular strength and endurance, perceived energy and cognitive
      performance in healthy adult males.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2014</start_date>
  <completion_date type="Actual">January 2015</completion_date>
  <primary_completion_date type="Actual">January 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Muscular Strength and Endurance compared to Placebo</measure>
    <time_frame>One day</time_frame>
    <description>Muscular Strength and Endurance will be measured by Bench Press and Leg Press 1-RM and repetitions to exhaustion.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline in Cognitive Performance</measure>
    <time_frame>Baseline to one-hour post dose and immediately post exercise</time_frame>
    <description>Cognitive performance will be measured by the automated trail maker tests A and B.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Change from Baseline in Perceived Energy and Fatigue</measure>
    <time_frame>Baseline to one-hour post dose and immediately post exercise</time_frame>
    <description>Perceived Energy and Fatigue will be measured by the Profile of Mood States.</description>
  </other_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">24</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Beverage A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Single dose, Pre-Workout Master Performance Blend Dose 1</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Beverage B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Single dose, Pre-Workout Master Performance Blend Dose 2</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Beverage C</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Single dose, Pre-Workout Performance Energy Blend</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Beverage D</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Single dose, Pre-Workout Energy Blend</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Beverage E</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Single dose, Pre-Workout Placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Master Performance Blend Dose 1</intervention_name>
    <description>Caffeine content: 200 mg</description>
    <arm_group_label>Beverage A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Master Performance Blend Dose 2</intervention_name>
    <description>Caffeine content: 400 mg</description>
    <arm_group_label>Beverage B</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Performance Energy Blend</intervention_name>
    <description>Caffeine content: 175 mg</description>
    <arm_group_label>Beverage C</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Energy Blend</intervention_name>
    <description>Caffeine content: 200 mg</description>
    <arm_group_label>Beverage D</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Caffeine content: 0 mg</description>
    <arm_group_label>Beverage E</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Males, aged 18 to 40 years

          2. Subject has a waist circumference ≤ 97 cm.

          3. Subject is a non-smoker.

          4. Subject is in good health and appropriate for exercise as determined by physical
             examination, medical history and ECG.

          5. Subject is weight training for the 6 months prior to starting the trial.

          6. Subject agrees to not use any new vitamins and/or minerals until after study
             completion and to not take any vitamins and/or minerals 24 hours prior to the test
             visits.

          7. Subject agrees to not use any dietary or herbal supplements until after study
             completion. A 7-day washout is allowed for study inclusion.

          8. Subject is willing and able to comply with the protocol including:

               -  Attending 5 visits each of which is approximately 4 hours long;

               -  Refraining from caffeine, over-the-counter medications and alcohol for the 24
                  hours prior to the test visits;

               -  Refraining from weight training for the 48 hours prior and refraining from any
                  exercise other than weight training for 24 hours prior to the test visits;

               -  Refraining from taking any dietary or herbal supplements throughout the study.

          9. Subject is able to understand and sign the informed consent to participate in the
             study.

        Exclusion Criteria:

          1. Subject has any of the following medical conditions:

               -  active heart disease

               -  uncontrolled high blood pressure (≥ 140/90 mmHg)

               -  renal or hepatic impairment/disease

               -  Type I or II diabetes

               -  bipolar disorder

               -  pulmonary disease (including current asthma)

               -  Parkinson's disease

               -  Seizure disorder

               -  unstable thyroid disease

               -  immune disorder (such as HIV/AIDS)

               -  active psychiatric disorders (including anxiety disorders)

               -  bleeding disorders

               -  gastrointestinal ulcer disease

               -  any medical condition deemed exclusionary by the Principal Investigator (PI)

          2. Subject has any orthopedic problem(s) or history of musculoskeletal injury(ies) which
             make(s) resistance weight training contraindicated.

          3. Subject has a history of cancer (except localized skin cancer without metastases)
             within 5 years prior to screening.

          4. No prescription or chronic medication use allowed without PI discretion.

          5. Subject is currently taking and unwilling to refrain from taking any over-the-counter
             stimulant medications/supplements (see section 2.6.2); seven-day washout required for
             study inclusion.

          6. Subject is currently taking and unwilling to refrain from taking any over-the-counter
             allergy or asthma medication containing pseudoephedrine or ephedrine (see section
             2.6.2); seven-day washout required for study inclusion.

          7. Subject has an allergy to milk and phenylalanine, or any of the ingredients in the
             test product (see section 3.2.1).

          8. Subject reports sensitivity to caffeine and/or beta-alanine.

          9. Subject reports being a regular caffeine consumer defined as consuming &gt; 600 mg of
             caffeine per day.

         10. Subject exhibits evidence of hepatic or renal dysfunction as evidenced by ALT, AST, AP
             being ≥ two times the upper limit of normal or serum creatinine value ≥ 2.0 mg/dl or
             other clinically significant abnormal clinical laboratory value per PI discretion.

         11. Subject has a clinically relevant abnormality as defined by the PI or interpreting
             physician with respect to the ECG.

         12. Subject has a QTcB interval &gt; 450 msec.

         13. Subject has a history of drug or alcohol abuse in the past 12 months.

         14. Subject has any condition or abnormality that, in the opinion of the investigator,
             would compromise the safety of the subject or the quality of the study data.

         15. Subject has taken an investigational product within 30 days of the first exercise test
             visit (visit 2).
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Miami Research Associates</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33143</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 26, 2014</study_first_submitted>
  <study_first_submitted_qc>September 29, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 2, 2014</study_first_posted>
  <last_update_submitted>April 6, 2015</last_update_submitted>
  <last_update_submitted_qc>April 6, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 7, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

